Sex differences in variables affecting short-term success in substance use disorder treatment

References

• Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive Disorders. Curr Psychiatry Rep. 2019;21(2):10. doi:10.1007/s11920-019-0997-0.
   PubMed Web of Science ®Google Scholar
• Jahan AR, Burgess DM, Substance Use Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
   Google Scholar
• Collaborators GCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88. doi:10.1016/S0140-6736(18)32203-7.
   PubMed Web of Science ®Google Scholar
• Collaborators GDaI. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22. doi:10.1016/S0140-6736(20)30925-9.
   PubMed Web of Science ®Google Scholar
• Xu B, LaBar KS. Advances in understanding addiction treatment and recovery. Sci Adv. 2019;5(10):eaaz6596. doi:10.1126/sciadv.aaz6596.
   PubMed Web of Science ®Google Scholar
• (US) SAaMHSA, (US) OotSG. Facing addiction in America: the Surgeon General’s Report on Alcohol, Drugs, and Health, 2016.
   Google Scholar
• Mark TL, Hinde JM, Barnosky A, Joshi V, Padwa H, Treiman K. Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? Drug Alcohol Depend. 2021;226:108868. doi:10.1016/j.drugalcdep.2021.108868.
   PubMed Web of Science ®Google Scholar
• Abreu Minero V, Best D, Brown L, Patton D, Vanderplasschen W. Differences in addiction and recovery gains according to gender - gender barriers and specific differences in overall strengths growth. Subst Abuse Treat Prev Policy. 2022;17(1):21. doi:10.1186/s13011-022-00444-8.
   PubMed Web of Science ®Google Scholar
• Evans EA, Grella CE, Washington DL, Upchurch DM. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. Drug Alcohol Depend. 2017;174:128–36. doi:10.1016/j.drugalcdep.2017.01.021.
   PubMed Web of Science ®Google Scholar
• Grella CE, Scott CK, Foss MA, Dennis ML. Gender similarities and differences in the treatment, relapse, and recovery cycle. Eval Rev. 2008;32(1):113–37. doi:10.1177/0193841X07307318.
   PubMed Web of Science ®Google Scholar
• Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1–21. doi:10.1016/j.drugalcdep.2006.05.012.
   PubMed Web of Science ®Google Scholar
• Frajzyngier V, Neaigus A, Gyarmathy VA, Miller M, Friedman SR. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend. 2007;89(2-3):145–52. doi:10.1016/j.drugalcdep.2006.12.021.
   PubMed Web of Science ®Google Scholar
• Schmidt L, Weisner C. The emergence of problem-drinking women as a special population in need of treatment. Recent Dev Alcohol. 1995;12:309–34.
   PubMedGoogle Scholar
• Kougiali ZG, Pytlik A, Soar K. Mechanisms and processes involved in women’s pathways into alcohol dependence and towards recovery: a qualitative meta-synthesis. Drugs Educ Prevent Policy. 2021;28(5):437–53.
   Web of Science ®Google Scholar
• Elms N, Link K, Newman A, Brogly SB. Need for women-centered treatment for substance use disorders: results from focus group discussions. Harm Reduct J. 2018;15(1):40. doi:10.1186/s12954-018-0247-5.
   PubMedGoogle Scholar
• Vanderplasschen W, Best D. Mechanisms and mediators of addiction recovery. Drugs Educ Prevent Policy. 2021;28(5):385–8.
   Web of Science ®Google Scholar
• Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. A review. Psychopathology 1998;31(3):160–8. doi:10.1159/000066239.
   PubMed Web of Science ®Google Scholar
• Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord. 2006;20(4):444–58. doi:10.1016/j.janxdis.2005.05.004.
   PubMed Web of Science ®Google Scholar
• Andersson HW, Steinsbekk A, Walderhaug E, Otterholt E, Nordfjaern T. Predictors of dropout from inpatient substance use treatment: a prospective cohort study. Substance Abuse-Res Treat. 2018;12:1–10.
   Web of Science ®Google Scholar
• Turan R, Yargic I. The relationship between substance abuse treatment completion, sociodemographics, substance use characteristics, and criminal history. Subst Abus. 2012;33(2):92–8. doi:10.1080/08897077.2011.630948.
   PubMed Web of Science ®Google Scholar
• Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997;11(4):261–78. doi:10.1037/0893-164X.11.4.261.
   Web of Science ®Google Scholar
• Simpson DD, Joe GW, Brown BS. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors. 1997;11(4):294–307. doi:10.1037/0893-164X.11.4.294.
   Web of Science ®Google Scholar
• Simpson DD, Joe GW, Broome KM, Hiller ML, Knight K, Rowan-Szal GA. Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors. 1997;11(4):279–93. doi:10.1037/0893-164X.11.4.279.
   Web of Science ®Google Scholar
• Harris AH, Kivlahan D, Barnett PG, Finney JW. Longer length of stay is not associated with better outcomes in VHA's substance abuse residential rehabilitation treatment programs. J Behav Health Serv Res. 2012;39(1):68–79. doi:10.1007/s11414-011-9250-2.
   PubMed Web of Science ®Google Scholar
• Witbrodt J, Bond J, Kaskutas LA, Weisner C, Jaeger G, Pating D, Moore C. Day hospital and residential addiction treatment: randomized and nonrandomized managed care clients. J Consult Clin Psychol. 2007;75(6):947–59. doi:10.1037/0022-006X.75.6.947.
   PubMed Web of Science ®Google Scholar
• Lejuez CW, Read JP, Kahler CW, Richards JB, Ramsey SE, Stuart GL, Strong DR, Brown RA. Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl. 2002;8(2):75–84. doi:10.1037//1076-898x.8.2.75.
   PubMed Web of Science ®Google Scholar
• Lejuez CW, Aklin WM, Jones HA, Richards JB, Strong DR, Kahler CW, Read JP. The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp Clin Psychopharmacol. 2003;11(1):26–33. doi:10.1037/1064-1297.11.1.26.
   PubMed Web of Science ®Google Scholar
• Schneider S, Peters J, Bromberg U, Brassen S, Miedl SF, Banaschewski T, Barker GJ, Conrod P, Flor H, Garavan H, et al. Risk taking and the adolescent reward system: a potential common link to substance abuse. Am J Psychiatry. 2012;169(1):39–46. doi:10.1176/appi.ajp.2011.11030489.
   PubMed Web of Science ®Google Scholar
• Long EC, Kaneva R, Vasilev G, Moeller FG, Vassileva J. Neurocognitive and Psychiatric Markers for Addiction: Common vs. Specific Endophenotypes for Heroin and Amphetamine Dependence. Curr Top Med Chem. 2020;20(7):585–597. doi:10.2174/1568026620666200131124608.
   PubMed Web of Science ®Google Scholar
• Laffaye C, McKellar JD, Ilgen MA, Moos RH. Predictors of 4-year outcome of community residential treatment for patients with substance use disorders. Addiction 2008;103(4):671–80. doi:10.1111/j.1360-0443.2008.02147.x.
   PubMed Web of Science ®Google Scholar
• Wells-Parker E. Mandated treatment: lessons from research with drinking and driving offenders. Alcohol Health Res World. 1994;18(4):302–6.
   PubMedGoogle Scholar
• Fynbo L. Risk, control and self-identity: young drunk drivers’ experiences with driving under the influence of alcohol and drugs. Nordic Stud Alcohol Drugs. 2014;31(3):229–43. doi:10.2478/nsad-2014-0019.
   Web of Science ®Google Scholar
• Cerimele JM, Katon WJ. Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: a systematic review. Gen Hosp Psychiatry. 2013;35(1):16–22. doi:10.1016/j.genhosppsych.2012.08.001.
   PubMed Web of Science ®Google Scholar
• Magura S, Rosenblum A, Betzler T. Substance use and mental health outcomes for comorbid patients in psychiatric day treatment. Subst Abuse. 2009;3:71–8.
   PubMedGoogle Scholar
• Degenhardt L, Saha S, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Andrade LH, Bromet EJ, Bruffaerts R, Caldas-de-Almeida JM, et al. The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys. Addiction 2018;113(5):924–34. doi:10.1111/add.14145.
   PubMed Web of Science ®Google Scholar
• Kiran C, Chaudhury S. Understanding delusions. Ind Psychiatry J. 2009;18(1):3–18. doi:10.4103/0972-6748.57851.
   PubMedGoogle Scholar
• Compton WM, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003;160(5):890–5. doi:10.1176/appi.ajp.160.5.890.
   PubMed Web of Science ®Google Scholar
• Gould TJ. Addiction and cognition. Addict Sci Clin Pract. 2010;5(2):4–14.
   PubMedGoogle Scholar
• Epton T, Currie S, Armitage CJ. Unique effects of setting goals on behavior change: systematic review and meta-analysis. J Consult Clin Psychol. 2017;85(12):1182–98. doi:10.1037/ccp0000260.
   PubMed Web of Science ®Google Scholar
• Friedman AS, Terras A, Zhu WZ, McCallum J. Depression, negative self-image, and suicidal attempts as effects of substance use and substance dependence. J Addict Dis. 2004;23(4):55–71. doi:10.1300/J069v23n04_05.
   PubMed Web of Science ®Google Scholar
• Esang M, Ahmed S. A closer look at substance use and suicide. Am J Psychiatry Resid J. 2018;13(6):6–8. doi:10.1176/appi.ajp-rj.2018.130603.
   Google Scholar
• NIDA. Why is there comorbidity between substance use disorders and mental illnesses? 13 Apr. 2021.
   Google Scholar
• Asaoka Y, Won M, Morita T, Ishikawa E, Goto Y. Higher risk taking and impaired probability judgment in behavioral addiction. Int J Neuropsychopharmacol. 2020;23(10):662–72. doi:10.1093/ijnp/pyaa044.
   PubMed Web of Science ®Google Scholar
• Greene K, Krcmar M, Walters LH, Rubin DL, Hale L., Jerold   Targeting adolescent risk-taking behaviors: the contributions of egocentrism and sensation-seeking. J Adolesc. 2000;23(4):439–61. doi:10.1006/jado.2000.0330.
   PubMed Web of Science ®Google Scholar
• Ersche KD, Turton AJ, Pradhan S, Bullmore ET, Robbins TW. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry. 2010;68(8):770–3. doi:10.1016/j.biopsych.2010.06.015.
   PubMed Web of Science ®Google Scholar
• NIDA. Characteristics of drug-dependent people, 2004.
   Google Scholar
• Hien DA, Nunes E, Levin FR, Fraser D. Posttraumatic stress disorder and short-term outcome in early methadone treatment. J Subst Abuse Treat. 2000;19(1):31–7. doi:10.1016/s0740-5472(99)00088-4.
   PubMed Web of Science ®Google Scholar
• Hser YI, Evans E, Teruya C, Huang D, Anglin MD. Predictors of short-term treatment outcomes among California’s Proposition 36 participants. Eval Program Plann. 2007;30(2):187–96. doi:10.1016/j.evalprogplan.2006.10.008.
   PubMed Web of Science ®Google Scholar
• Christopher PP, Pinals DA, Stayton T, Sanders K, Blumberg L. Nature and utilization of civil commitment for substance abuse in the United States. J Am Acad Psychiat Law. 2015;43(3):313–20.
   PubMed Web of Science ®Google Scholar
• Jain A, Christopher P, Appelbaum PS. Civil commitment for opioid and other substance use disorders: does it work? PS 2018;69(4):374–6. doi:10.1176/appi.ps.201800066.
   Google Scholar
• Weisner C, Thomas Ray G, Mertens JR, Satre DD, Moore C. Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug Alcohol Depend. 2003;71(3):281–94. doi:10.1016/s0376-8716(03)00167-4.
   PubMed Web of Science ®Google Scholar
• Taghva M, Shiraly R, Moghimi Sarani E. Exploring the demographic factors and facilitators to addiction abstinence. GMJ. 2018;7:e1074. doi:10.31661/gmj.v7i0.1074.
   Google Scholar